Pfizer to sell entire Haleon stake
Pfizer will sell its remaining stake in British consumer healthcare group Haleon , the companies said on Tuesday.
Pfizer (NYSE:PFE) To Divest Entire 7 Percent Stake In Haleon Through Share Offering
Pfizer (NYSE:PFE) announced its intention to sell its entire residual shareholding in Haleon plc, reflecting a divestment ...
Pfizer Sells Final Haleon Shares for $3.2B, Ends Stake in Consumer Healthcare Giant
Pfizer has finalized the sale of its entire holding in Haleon , generating approximately 2.5 billion ($3.24 billion), Reuters ...
Pfizer Offloads Its Last 7% Stake In Consumer Health Haleon For Over $3 Billion
Pfizer has completed its exit from Haleon, selling its entire stake for $3.1 billion. BlackRock's unit is now Haleon's ...
Pfizer exits Haleon stake after $3.2B share sale
Pfizer (PFE) stock in focus as the company sells its entire 7.3% stake in Haleon (HLN) for $3.24B. Read more here.
Drug Store News4d
Pfizer reportedly raises $3.3B from sale of remaining Haleon stake
Pfizer reportedly offered about 618 million shares through a placement with investors, according to a Wednesday statement.
Fierce Pharma4d
Pfizer pockets roughly £2.5B as it shaves off final stake in consumer health spinoff Haleon
With Pfizer’s final stake sale in the bag, the two Big Pharma companies behind Haleon’s genesis have formally parted ways with the standalone consumer health giant. | After charting similar moves ...
Notable healthcare headlines for the week: Pfizer, Sanofi, Sarepta Therapeutics and Medtronic in focus
Discover the top gainers and losers in the S&P 500 Healthcare Index and stay updated on major news like J&J's $55B investment and Pfizer's Haleon stake exit.
The Business Times4d
Pfizer sells entire Haleon stake for US$3.24 billion
Bengaluru] Drugmaker Pfizer has sold its entire stake in Haleon for about US$3.24 billion to institutional investors and the ...